|
Volumn 23, Issue 11, 2002, Pages 1961-1963
|
Redox-regulated mechanism may account for zerumbone's ability to suppress cancer-cell proliferation (multiple letters)
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CARBONYL DERIVATIVE;
GLUTATHIONE;
RETINOBLASTOMA PROTEIN;
SESQUITERPENE DERIVATIVE;
UNCLASSIFIED DRUG;
ZERUMBONE;
ANTINEOPLASTIC ACTIVITY;
APOPTOSIS;
CANCER CELL;
CELL CYCLE G1 PHASE;
CELL PROLIFERATION;
COLON CANCER;
CONTROLLED STUDY;
LETTER;
MICHAEL ADDITION;
OXIDATION REDUCTION POTENTIAL;
OXIDATION REDUCTION REACTION;
PRIORITY JOURNAL;
PROTEIN PHOSPHORYLATION;
REGULATORY MECHANISM;
ADENOCARCINOMA;
ANIMALS;
ANTINEOPLASTIC AGENTS, PHYTOGENIC;
APOPTOSIS;
CELL CYCLE;
CELL DIVISION;
COLONIC NEOPLASMS;
FIBROBLASTS;
FIBROSARCOMA;
GLUTATHIONE;
HUMANS;
OXIDATION-REDUCTION;
PHOSPHORYLATION;
PHYTOTHERAPY;
PROTEIN PROCESSING, POST-TRANSLATIONAL;
RETINOBLASTOMA PROTEIN;
SESQUITERPENES;
STRUCTURE-ACTIVITY RELATIONSHIP;
TUMOR STEM CELLS;
|
EID: 0036849565
PISSN: 01433334
EISSN: None
Source Type: Journal
DOI: None Document Type: Letter |
Times cited : (25)
|
References (0)
|